Literature DB >> 21944556

Chagas disease in European countries: the challenge of a surveillance system.

L Basile1, J M Jansa, Y Carlier, D D Salamanca, A Angheben, A Bartoloni, J Seixas, T Van Gool, C Canavate, M Flores-Chavez, Y Jackson, P L Chiodini, P Albajar-Vinas.   

Abstract

A study of aggregate data collected from the literature and official sources was undertaken to estimate expected and observed prevalence of Trypanosoma cruzi infection, annual incidence of congenital transmission and rate of underdiagnosis of Chagas disease among Latin American migrants in the nine European countries with the highest prevalence of Chagas disease. Formal and informal data sources were used to estimate the population from endemic countries resident in Europe in 2009, diagnosed cases of Chagas disease and births from mothers originating from endemic countries. By 2009, 4,290 cases had been diagnosed in Europe, compared with an estimated 68,000 to 122,000 expected cases. The expected prevalence was very high in undocumented migrants (on average 45% of total expected cases) while the observed prevalence rate was 1.3 cases per 1,000 resident migrants from endemic countries. An estimated 20 to 183 babies with congenital Chagas disease are born annually in the study countries. The annual incidence rate of congenital transmission per 1,000 pregnancies in women from endemic countries was between none and three cases. The index of under diagnosis of T. cruzi infection was between 94% and 96%. Chagas disease is a public health challenge in the studied European countries. Urgent measures need to be taken to detect new cases of congenital transmission and take care of the existing cases with a focus on migrants without legal residency permit and potential difficulty accessing care.

Entities:  

Mesh:

Year:  2011        PMID: 21944556

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  90 in total

1.  Coadministration of cruzipain and GM-CSF DNAs, a new immunotherapeutic vaccine against Trypanosoma cruzi infection.

Authors:  Natacha Cerny; Andrés Sánchez Alberti; Augusto E Bivona; Mauricio C De Marzi; Fernanda M Frank; Silvia I Cazorla; Emilio L Malchiodi
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

2.  Prevalence of Chagas Disease among Solid Organ-Transplanted Patients in a Nonendemic Country.

Authors:  Fernando Salvador; Adrián Sánchez-Montalvá; Elena Sulleiro; Francesc Moreso; Cristina Berastegui; Mireia Caralt; María-Jesús Pinazo; Zaira Moure; Ibai Los-Arcos; Oscar Len; Joan Gavaldà; Israel Molina
Journal:  Am J Trop Med Hyg       Date:  2018-02-01       Impact factor: 2.345

3.  Serological Diagnosis of Chronic Chagas Disease: Is It Time for a Change?

Authors:  Alba Abras; Montserrat Gállego; Teresa Llovet; Silvia Tebar; Mercedes Herrero; Pere Berenguer; Cristina Ballart; Carmen Martí; Carmen Muñoz
Journal:  J Clin Microbiol       Date:  2016-04-06       Impact factor: 5.948

4.  Chagas Disease in a Non-endemic Country: A Multidisciplinary Research, Bologna, Italy.

Authors:  Chiara Di Girolamo; Giulia Martelli; Anna Ciannameo; Caterina Vocale; Marco Fini; Angelo Stefanini; Maria Paola Landini; Pierluigi Viale; Gabriella Verucchi
Journal:  J Immigr Minor Health       Date:  2016-06

5.  Chagas disease in non-endemic countries: epidemiology, clinical presentation and treatment.

Authors:  José A Pérez-Molina; Francesca Norman; Rogelio López-Vélez
Journal:  Curr Infect Dis Rep       Date:  2012-06       Impact factor: 3.725

Review 6.  Diagnosis and management of Chagas disease and cardiomyopathy.

Authors:  Antonio L Ribeiro; Maria P Nunes; Mauro M Teixeira; Manoel O C Rocha
Journal:  Nat Rev Cardiol       Date:  2012-07-31       Impact factor: 32.419

7.  Emerging and under-recognized Chagas cardiomyopathy in non-endemic countries.

Authors:  Joana Cortez; Rui Providência; Evelise Ramos; Cristina Valente; Jorge Seixas; Manuela Meruje; António Leitão-Marques; António Vieira
Journal:  World J Cardiol       Date:  2012-07-26

Review 8.  Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease.

Authors:  Fabiana S Machado; Walderez O Dutra; Lisia Esper; Kenneth J Gollob; Mauro M Teixeira; Stephen M Factor; Louis M Weiss; Fnu Nagajyothi; Herbert B Tanowitz; Nisha J Garg
Journal:  Semin Immunopathol       Date:  2012-10-18       Impact factor: 9.623

9.  Serum-mediated activation of macrophages reflects TcVac2 vaccine efficacy against Chagas disease.

Authors:  Shivali Gupta; Trevor S Silva; Jessica E Osizugbo; Laura Tucker; Heidi M Spratt; Nisha J Garg
Journal:  Infect Immun       Date:  2014-01-13       Impact factor: 3.441

Review 10.  A global systematic review of Chagas disease prevalence among migrants.

Authors:  Erin E Conners; Joseph M Vinetz; John R Weeks; Kimberly C Brouwer
Journal:  Acta Trop       Date:  2016-01-08       Impact factor: 3.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.